Sotiri Stathakis | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Sotiri Stathakis | Medicine and Dentistry | Best Researcher Award

Mary Bird Perkins Cancer Center | United States

Dr. Sotirios Stathakis is an accomplished medical physicist with extensive experience in radiation oncology, advanced treatment planning, and patient safety in cancer care. Currently serving as the Chief of Physics at Mary Bird Perkins Cancer Center and Adjunct Professor at Louisiana State University, he has established himself as a leader in both clinical and academic domains. His work bridges fundamental research and real-world clinical application, focusing on improving the accuracy, efficiency, and safety of radiotherapy treatments. With a career spanning over two decades, Dr. Stathakis has played a pivotal role in advancing technologies such as intensity-modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT), Monte Carlo simulations, and adaptive radiotherapy. He has supervised graduate students, medical residents, and postdoctoral fellows, contributing to the development of the next generation of medical physicists. Dr. Stathakis is internationally recognized for his innovative contributions to medical physics, publishing widely in peer-reviewed journals and presenting at global conferences. His leadership in quality assurance (QA) protocols, radiotherapy safety standards, and patient-centered innovations has earned him professional recognition as a Fellow of the American Association of Physicists in Medicine (AAPM). He continues to expand his research by integrating artificial intelligence, patient education, and wearable technology into cancer care.

Professional Profile

Scopus | ORCID

Education

Dr. Sotirios Stathakis has a strong academic background rooted in physics and medical physics, which forms the foundation of his distinguished career in cancer treatment and research. He began his academic journey with a Bachelor of Science in Physics from the University of Waterloo, Canada, where he developed a strong foundation in core physical sciences and problem-solving skills. Driven by an interest in applying physics to medicine, he pursued a Master of Science in Medical Physics at the University of Aberdeen, United Kingdom. Here, he received specialized training in radiological sciences, medical imaging, and radiotherapy applications, which fueled his passion for research in patient care. His academic progression culminated in a Ph.D. in Medical Physics from the University of Patras, Greece, where his doctoral work focused on advanced radiation dosimetry and optimization of treatment planning systems. His doctoral training allowed him to explore Monte Carlo simulations and radiation safety protocols, which later became key aspects of his professional contributions. This comprehensive education, spanning North America and Europe, equipped him with a unique global perspective and multidisciplinary expertise. It also prepared him to integrate clinical practice with research, ultimately shaping his career as a recognized leader in medical physics and radiation oncology.

Professional Experience

Dr. Sotirios Stathakis has accumulated diverse professional experience that reflects his dual commitment to academic research and clinical application. He began his career in Europe, contributing to medical physics research before moving to the United States, where he established himself in leading academic and clinical institutions. At the University of Texas Health Science Center San Antonio (UTHSA), he served as a Professor and Medical Physicist, taking on responsibilities that included treatment planning, clinical implementation of new radiotherapy techniques, and the supervision of graduate students and medical residents. His academic contributions included teaching advanced courses in radiation oncology physics and mentoring Ph.D. dissertations. He later transitioned to his current role as Chief of Physics at Mary Bird Perkins Cancer Center, where he oversees medical physics operations across multiple oncology centers. In this role, he leads a team of physicists and ensures the safe and effective delivery of radiation treatments to cancer patients. His position as Adjunct Professor at Louisiana State University complements his clinical work, as he continues to teach and mentor the next generation of medical physicists. Throughout his career, Dr. Stathakis has balanced leadership, clinical service, and research, contributing to advancements in both patient care and academic knowledge.

Research Interests

Dr. Sotirios Stathakis’s research interests lie at the intersection of clinical innovation, radiation therapy optimization, and patient-centered approaches. A central focus of his research is the improvement of treatment planning systems, particularly through advanced modeling such as Monte Carlo simulations, which enhance accuracy in dose calculations. He has contributed to the development and refinement of quality assurance (QA) protocols, ensuring precision in intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT). Another important area of his research includes studying the secondary cancer risks associated with radiotherapy, providing valuable insights into long-term patient safety. Dr. Stathakis is also exploring the role of artificial intelligence (AI) in radiotherapy, particularly for dose prediction and workflow optimization, which has the potential to revolutionize clinical practices. In recent years, he has expanded his focus to include patient-centered technologies, such as wearable monitoring devices and virtual reality tools that improve patient education, engagement, and treatment compliance. His interdisciplinary approach combines physics, engineering, computer science, and clinical oncology, creating innovative solutions to complex healthcare challenges. By bridging these fields, Dr. Stathakis continues to advance the standards of radiotherapy, contributing to safer, more effective, and personalized cancer treatments.

Research Skills

Dr. Sotirios Stathakis possesses a broad range of research skills that span computational modeling, experimental validation, clinical trial design, and academic mentoring. His expertise in Monte Carlo simulations allows him to perform highly accurate radiation dose calculations, a critical aspect of treatment planning and safety assessment in radiation oncology. He is also highly skilled in advanced quality assurance techniques, particularly for IMRT and VMAT, ensuring reliable and precise delivery of radiation therapy. Dr. Stathakis is proficient in using and commissioning treatment planning systems and linear accelerators, applying both theoretical and practical approaches to improve clinical workflows. His research methodology incorporates statistical analysis, machine learning, and artificial intelligence, enabling him to address complex problems in treatment optimization and patient safety. Beyond technical skills, he excels in collaborative project management, coordinating interdisciplinary teams across physics, medicine, and engineering. His experience extends to academic publishing, peer review, and conference presentations, reflecting his ability to effectively disseminate scientific findings. As a mentor and educator, he has guided Ph.D. students and medical residents in developing independent research projects, further demonstrating his leadership in research environments. Collectively, these skills highlight his ability to translate advanced scientific concepts into practical innovations that benefit cancer patients worldwide.

Awards and Honors

Throughout his career, Dr. Sotirios Stathakis has received numerous awards and honors in recognition of his academic excellence, clinical leadership, and professional service. One of the most prestigious distinctions in his career is being named a Fellow of the American Association of Physicists in Medicine (AAPM), a recognition reserved for members who have made significant contributions to the advancement of medical physics. He is also board-certified in Therapeutic Radiologic Physics by the American Board of Radiology (ABR), underscoring his professional expertise and credibility in clinical practice. His academic work has been acknowledged through invitations to present at leading international conferences, including those organized by IEEE, AAPM, and ESTRO, where he has shared groundbreaking findings on radiotherapy optimization and quality assurance. In addition, Dr. Stathakis has served as a peer reviewer for high-impact journals such as the Journal of Applied Clinical Medical Physics (JACMP), further highlighting his standing in the scientific community. He has also been recognized by institutions where he has taught and worked, receiving commendations for excellence in mentorship and clinical service. These honors reflect his consistent commitment to innovation, patient safety, and education, solidifying his reputation as a respected leader in medical physics and radiation oncology.

Publication Top Notes

  • AAPM TG report 312: Acceptance testing, commissioning, and periodic quality assurance of ion chamber and diode detector arrays — 2025

  • Dosimetric characterization of a new surface-conforming electron MLC prototype — 2024 — 1 citation

  • Monte Carlo modeling of the Elekta Versa HD and patient dose calculation with EGSnrc/BEAMnrc — 2022 — 5 citations

  • Erratum to: Report of AAPM Task Group 219 on independent calculation-based dose/MU verification for IMRT — 2021

  • Artificial intelligence based deconvolving on megavoltage photon beam profiles for radiotherapy applications — 2022

  • A customizable aluminum compensator system for total body irradiation — 2021

Conclusion

Dr. Sotirios Stathakis’s career represents a remarkable combination of academic excellence, clinical innovation, and professional leadership. His work has transformed multiple aspects of radiation oncology, from enhancing treatment planning accuracy to implementing robust quality assurance protocols that safeguard patient outcomes. With a strong foundation in education from top institutions across Canada, the United Kingdom, and Greece, coupled with his leadership roles in the United States, he exemplifies the global nature of medical physics. His research interests and skills reflect both scientific rigor and compassion, as he continually integrates patient-centered approaches into his innovations. Recognized internationally through awards, honors, and professional certifications, Dr. Stathakis has established himself as a trusted authority in his field. His mentorship of students and collaboration with clinicians ensure that his influence extends beyond his individual achievements, shaping the future of cancer care. Looking ahead, his engagement with artificial intelligence, wearable technology, and advanced radiotherapy models positions him to make further groundbreaking contributions. In sum, Dr. Stathakis embodies the qualities of a dedicated researcher, educator, and clinician, making him not only a leader in medical physics but also a driving force in advancing the fight against cancer globally.

Maria Kourti | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Prof. Maria Kourti | Medicine and Dentistry | Best Researcher Award

Aristotle University of Thessaloniki | Greece

Prof. Maria Kourti is a distinguished academic and medical professional specializing in Pediatrics with a particular focus on Pediatric Hematology, Oncology, and Infectious Diseases. She currently serves as an Assistant Professor at Aristotle University of Thessaloniki, where she has been deeply involved in both teaching and research. Her career spans over two decades of excellence in clinical practice, scientific research, and international collaborations, with significant contributions to the understanding of childhood leukemia, drug resistance mechanisms, and pediatric infectious diseases. She has authored 73 publications indexed in PubMed, holds an h-index of 16, and has received over 1,000 citations, making her a recognized figure in her field. Prof. Kourti has combined clinical expertise with cutting-edge molecular and proteomic research, actively leading and participating in international multicenter studies and clinical trials. She is also extensively engaged in professional societies at the European and global levels, serving as a board member and committee leader in organizations dedicated to pediatric health. Alongside her academic achievements, she has contributed to medical education, mentorship, and health promotion initiatives, underlining her holistic approach to advancing both science and society. Her distinguished record makes her a highly respected leader in pediatric research and medicine.

Professional Profile

Scopus | ORCID 

Education

Prof. Maria Kourti pursued her entire academic journey at the Aristotle University of Thessaloniki, Greece, one of the most prestigious institutions in the country. She obtained her Medical Degree, laying the foundation for her career in pediatrics. With a strong interest in scientific research, she further advanced her education by earning a Master of Science (MSc) in Medical Research Technology, where she developed early expertise in biomedical investigations. Her passion for oncology and molecular medicine culminated in her Ph.D, with her thesis focused on the “Study of expression of multi-drug resistance genes in pediatric leukemia,” a topic that remains central to her research today. Her commitment to academic and clinical growth did not stop there, as she pursued advanced medical specialization, becoming Board Certified as a Specialist Pediatrician and later recognized as a Pediatric Infectious Disease Specialist. In the same year, she also completed a Post-Doctoral Fellowship in Proteomics in Childhood Leukemia, marking her continued dedication to translational research. This progression highlights her unique integration of medicine and science, equipping her with the academic depth and clinical expertise to make pioneering contributions in pediatric hematology, oncology, and infectious diseases.

Professional Experience

Prof. Maria Kourti has held several critical roles in clinical practice and academia, reflecting her dual expertise as a physician and researcher. she served as an Attending Physician in the Pediatric Oncology Department at Hippokration General Hospital, where she gained extensive clinical experience in treating children with hematological malignancies and solid tumors. Her expertise further deepened during her Pediatric Infectious Disease Fellowship at Aristotle University of Thessaloniki, based at Hippokration General Hospital. she worked as an Attending Physician in the 3rd Department of Pediatrics at Aristotle University, responsible for managing the Pediatric Hematology Unit, demonstrating her leadership in both patient care and academic responsibilities. she was appointed Assistant Professor of Pediatrics–Pediatric Hematology and Oncology at Aristotle University of Thessaloniki, where she continues to combine clinical duties with teaching and high-level research. Her responsibilities extend beyond the university, as she actively participates in national and international research programs, leading initiatives on childhood cancer, supportive care, and clinical trials. Through these roles, Prof. Kourti has developed a reputation for clinical excellence, academic leadership, and research innovation, making her a central figure in pediatric hematology and oncology in Greece and abroad.

Research Interests

Prof. Kourti’s research interests span the intersection of molecular biology, pediatric oncology, and infectious diseases, with a strong emphasis on improving treatment outcomes for children with cancer. Her doctoral and postdoctoral work centered on the molecular mechanisms of drug resistance in childhood leukemia, specifically the expression of multi-drug resistance genes and the application of proteomics to understand disease progression and treatment response. She has also been deeply engaged in genetic polymorphism studies, particularly in metabolic enzymes of carcinogenic substances in patients with acute leukemias and myelodysplastic syndromes. In addition to her oncology work, she has pursued significant research in pediatric infectious diseases, coordinating national efforts for the Greek Supportive Care Group and contributing to clinical research on antifungal therapies and novel antimicrobial strategies. Her interests also extend to large-scale clinical collaborations, where she has been both principal and sub-investigator in 15 multinational clinical trials addressing treatments for pediatric cancers and infections. This breadth of research demonstrates her commitment to translational medicine, bridging laboratory research with clinical applications. Her interests align with global health priorities, focusing on improving survival, reducing treatment toxicity, and enhancing supportive care in children with cancer.

Research Skills

Prof. Kourti possesses a strong foundation in molecular biology and clinical research methodologies, supported by advanced training and decades of practical application. Her technical expertise includes DNA and RNA extraction from blood and bone marrow samples, agarose gel electrophoresis, PCR, and RT-PCR, enabling her to investigate genetic and proteomic markers in pediatric leukemia. She has extensive experience with clinical trial design and implementation, having served as both a principal investigator and sub-investigator in numerous international studies, particularly within the SIOPE and SIOPEN networks. Her skills also extend to multidisciplinary collaboration, coordinating research teams across clinical and laboratory settings. In addition, Prof. Kourti has developed editorial and peer-review skills through her role as Guest Editor of special issues in international journals such as the Journal of Fungi and Diagnostics and as a reviewer for more than 10 medical journals. She also demonstrates expertise in data interpretation, publication writing, and conference presentation, with over 100 oral and poster presentations at national and international congresses. Her combined clinical and laboratory research skills, along with her organizational and editorial experience, make her a versatile and influential contributor to pediatric oncology and infectious disease research worldwide.

Awards and Honors

Throughout her career, Prof. Maria Kourti has received numerous awards and honors recognizing her excellence in research, teaching, and clinical practice. She has earned 10 major distinctions, including 3 scholarships from the National Scholarship Foundation (IKY), awarded for her academic performance and research potential. In addition, she has received 3 educational grants supporting her clinical and research training, as well as 6 first prizes for oral and poster presentations at both national and international medical congresses. These awards highlight not only her dedication to scientific inquiry but also her ability to effectively communicate her findings to diverse audiences. Beyond individual recognition, her leadership roles within professional societies such as the Hellenic Society for Social Pediatrics and Health Promotion, the National Pediatric Hematology and Oncology Society, and participation in European cooperative groups (SIOPE, ESPID, EXPeRT, ESCMID) further demonstrate the esteem in which she is held by the medical and scientific community. She has also contributed as a committee member for sustainability at ESPID, reflecting her commitment to long-term scientific advancement and ethical research practices. These honors collectively underscore her outstanding achievements and her influential role in pediatric medicine and research.

Publication Top Notes

  • Antifungal Use in Immunocompromised Children in Europe: A 12-Week Multicenter Weekly Point Prevalence Survey (CALYPSO) — 2025

  • A Global Analysis of Cases of Mucormycosis Recorded in the ECMM / ISHAM Zygomyco.net Registry from 2009 to 2022 — 2025

  • Medulloblastoma therapy: Consensus treatment recommendations from SIOP-Europe and the European Research Network — 2025 — 3 citations

  • Addressing infectious challenges in pediatric cancer and hematopoietic cell transplantation: insights from the Umbrella Working Group — 2025

  • Invasive Fungal Disease After Chimeric Antigen Receptor-T Immunotherapy in Adult and Pediatric Patients — 2025

  • Planetary Health: What You Need to Know as a Pediatric Infectious Diseases Doctor — 2025

  • Successful Treatment of Disseminated Fusariosis in a 15-Month-old Boy With Refractory Acute Lymphoblastic Leukemia Using High-dose Voriconazole — 2024 — 1 citation

  • Usage of Antifungal Agents in Pediatric Patients Versus Adults: Knowledge and Gaps — 2025

Conclusion

Prof. Maria Kourti exemplifies the qualities of a leading physician-scientist, with a career that integrates clinical expertise, innovative research, and academic leadership. Her groundbreaking work in childhood leukemia, infectious diseases, and pediatric oncology has advanced both scientific knowledge and clinical practice, directly impacting patient outcomes. With more than 73 peer-reviewed publications, extensive participation in international clinical trials, and leadership in national and European research groups, she has established herself as a key figure in the global pediatric research community. Her commitment to mentoring young scientists, active involvement in health promotion initiatives, and editorial contributions further enhance her academic profile. Looking ahead, Prof. Kourti is well-positioned to expand her research into global collaborations, increase her presence in high-impact journals, and take on greater leadership roles in shaping international pediatric oncology policies. Her career trajectory reflects not only past accomplishments but also significant potential for future contributions to medicine, making her a highly deserving candidate for continued recognition. In summary, Prof. Kourti’s lifelong dedication to advancing pediatric care and medical science positions her as an outstanding role model and leader in the field.

Pedro Antonio Regidor | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Pedro Antonio Regidor | Medicine and Dentistry | Best Researcher Award

Medical Director from Exeltis Healthcare | Germany 

Dr. Pedro Antonio Regidor is a dual-national (Spanish and German) medical doctor and scientist with over three decades of clinical and leadership experience in the field of gynecology and obstetrics. He is currently the Medical Director of Exeltis Europe & Global Projects, overseeing pharmaceutical initiatives and innovations in women’s health across international markets. Dr. Regidor is a specialist in gynecological oncology, reproductive medicine, surgical gynecology, and perinatal care, and has performed thousands of complex surgeries and deliveries. His clinical expertise is reinforced by his academic contributions, having earned an MD in 1992 and a PhD in 2000 from the University of Essen. He has held several key roles in prominent German institutions such as the University of Essen, Westfälische Wilhelms-Universität Münster, and Klinikum Osnabrück. In addition, he has served in leadership roles within private medical consultancies and pharmaceutical companies. Dr. Regidor’s career reflects a dynamic integration of patient care, medical research, academic excellence, and corporate strategy. Through his work with Exeltis and affiliations with multiple scientific boards, he continues to shape the future of gynecological healthcare and pharmaceutical development on a global scale.

Professional Profile

Scopus Profile | ORCID Profile

Education

Dr. Regidor’s academic foundation is built on a robust medical and scientific education acquired in Germany. He earned his Doctor of Medicine (MD) on 21 March 1992, with a thesis focused on immunohistochemical detection of progesterone receptors in various tissues. His pursuit of advanced knowledge continued with a PhD in Gynecology and Obstetrics awarded by the University of Essen on 14 April 2000, based on research into peritoneal endometriosis. His studies not only demonstrated academic excellence but also provided the groundwork for his specializations in women’s health. Throughout his educational journey, he gained comprehensive training in multiple sub-disciplines, including endocrine disorders, surgical gynecology, and diagnostic imaging techniques such as mammography and hysterosalpingography. Dr. Regidor also pursued professional licensure in multiple countries, including Germany and Switzerland, reflecting his global perspective and adaptability in medical practice. He earned several professional qualifications between 1995 and 2006, officially recognized as a specialist in gynecology and obstetrics, gynecological endocrinology, reproductive medicine, and gynecological oncology. His academic credentials have empowered him to lead not only in clinical settings but also in the pharmaceutical and medical research sectors, demonstrating a lifelong commitment to education and advancement in medical science.

Professional Experience

Dr. Pedro Antonio Regidor has accumulated over 30 years of diverse professional experience, ranging from university hospitals and private clinics to high-level executive roles in the pharmaceutical industry. He began his medical career as a junior and medical resident at the University of Essen, focusing on gynecological oncology. His international exposure included a residency at Clínica Maternidad Concepción Palacios in Caracas, Venezuela, which enriched his global medical perspective. He later served as Assistant Medical Director in Essen and at Westfälische Wilhelms-Universität Münster, eventually becoming Chief of the Department of Gynecology and Obstetrics at Klinikum Osnabrück. Following years of leading hospital-based services, Dr. Regidor transitioned into private consultancy and pharmaceutical leadership roles. Since 2009, he has been affiliated with Frauenklinik München West and worked in executive medical roles for Velvian Germany GmbH and Exeltis. Currently, he is Medical Director of Exeltis Europe & Global Projects, managing international clinical and product development strategies. His career is distinguished by thousands of complex surgeries, strategic oversight of medical centers, and leadership in multinational pharmaceutical operations. His ability to bridge clinical knowledge with organizational leadership makes him a rare expert in both hands-on patient care and large-scale medical innovation.

Research Interests

Dr. Regidor’s research interests lie primarily in gynecological oncology, reproductive medicine, endocrinology, and women’s health diagnostics and therapeutics. He has a strong academic inclination toward understanding the pathophysiology of endometriosis, as evidenced by his PhD research on immunohistochemical investigations. He is particularly focused on the integration of clinical evidence with pharmacological innovation, developing solutions that address unmet needs in hormone replacement therapy, fertility regulation, and perinatal management. Through his leadership at Exeltis, he also explores new formulations of estrogen and progesterone therapies, especially in menopausal care and contraceptive technologies. Dr. Regidor is deeply invested in the development and validation of clinical protocols for surgical interventions, breast reconstruction, hormone diagnostics, and cancer therapy. He continues to engage in international collaborative research projects, particularly in clinical trials involving women’s hormone treatments and breast cancer. Additionally, he serves on scientific boards and advisory committees that drive research agendas in reproductive endocrinology and gynecological oncology. His work frequently intersects clinical application with scientific innovation, making him a key figure in translational medicine.

Research Skills

Dr. Regidor possesses a highly specialized skill set that encompasses both clinical research and surgical expertise. He is proficient in conducting immunohistochemical analyses, clinical trial coordination, and protocol development. His strong foundation in gynecological diagnostics allows him to interpret laboratory results with precision and apply them directly in surgical and medical decision-making. His surgical record is extensive, with over 7,000 procedures ranging from total laparoscopic hysterectomies to breast reconstructions, demonstrating exceptional hands-on expertise. In research contexts, he is adept at designing clinical studies, interpreting biomedical data, and ensuring ethical compliance across international sites. He has a deep understanding of hormonal pathways, disease modeling, and advanced imaging techniques, including radiological diagnostics for gynecologic applications. Dr. Regidor is also skilled in multilingual communication, enabling him to effectively collaborate on global research initiatives. Furthermore, his involvement with pharmaceutical companies has honed his abilities in regulatory science, medical writing, and strategic development of therapeutic pipelines. His combined skills in surgery, diagnostics, and clinical research make him a versatile asset in both academic and industry settings.

Awards and Honors

Over the course of his distinguished career, Dr. Pedro-Antonio Regidor has received numerous appointments and recognitions reflective of his impact in gynecology and medical leadership. While his career is not defined by traditional academic awards, his leadership roles themselves signify recognition by his peers and institutions. He served as Coordinator and Founding Member of the Breast Center in Münster, a pioneering initiative that contributed to Germany’s breast cancer diagnostic network. His repeated appointments as Medical Director at Velvian Germany GmbH and Exeltis Germany, Europe, and Global Projects further underscore his reputation as a trusted leader in the medical and pharmaceutical sectors. Additionally, he has been entrusted with consultancy roles for companies like Lipocine Inc. (USA) in the field of hormone therapy, showcasing global acknowledgment of his expertise. He holds membership in over ten professional societies, including the German Society for Gynecology and Obstetrics, West German Tumor Center, and scientific advisory boards related to endometriosis and reconstructive surgery. These positions not only validate his contributions but also recognize his ability to drive forward scientific agendas with clinical relevance.

Publications Top Notes

  • Effect over coagulation and fibrinolysis parameters of a prolonged-release contraceptive (2025) – Gynecological Endocrinology – 1 citation.

  • Prevalence of cumulative cardiovascular risk factors among French women of childbearing age: GYNRISK® survey (2025) – Journal of Gynecology Obstetrics and Human Reproduction – 1 citation.

  • Randomised trial comparing bleeding profiles of prolonged vs immediate-release contraceptives (2025) – European Journal of Contraception and Reproductive Health Care – 3 citations.

  • Anti-inflammatory effects of marine oil enriched with SPMs in Post-COVID Syndrome patients (2024) – Biomedicines – 4 citations.

  • Marine oil supplements during pregnancy to prevent preterm delivery (Review).

  • Omega-3 fatty acids and their role in pregnancy complications like preeclampsia and chorioamnionitis (Review)

Conclusion

Dr. Pedro-Antonio Regidor stands out as a multifaceted leader in gynecology, medical research, and pharmaceutical innovation. His extensive clinical experience, combined with a strong academic foundation and strategic leadership in the pharmaceutical industry, positions him uniquely at the intersection of science and healthcare delivery. He has made significant contributions to women’s health through his pioneering surgical interventions, research in reproductive medicine, and development of hormone-based therapies. His roles in clinical practice, academia, and corporate governance reflect a deep commitment to advancing medical science and improving patient care. Dr. Regidor’s work has positively impacted thousands of patients and influenced the direction of therapeutic innovation across Europe and beyond. With ongoing involvement in global projects and advisory boards, he is poised to further shape the landscape of gynecological healthcare and translational research. His career exemplifies excellence, leadership, and a tireless pursuit of medical advancement, making him a highly deserving candidate for recognition in international research and medical awards.

Farid Badria | Health Professions | Best Researcher Award

Published on by Shen Awards

Prof. Dr. Farid Badria | Health Professions | Best Researcher Award

Mansoura University, Egypt

Dr. Farid A. Badria is a distinguished Professor of Pharmacognosy at the Faculty of Pharmacy, Mansoura University, Egypt, where he also leads the Liver Research Lab (FAB-Lab). With a career spanning over three decades, he has emerged as a leading expert in natural products research, biomedical sciences, and translational medicine. His research portfolio encompasses phytochemistry, biotechnology, drug discovery, liver diseases, and diagnostic biomarker development. A globally recognized scholar, Dr. Badria’s academic contributions have earned him several prestigious awards, including recognition by Stanford University among the top 2% most-cited scientists in his field. He has held visiting positions at top institutions such as the University of Minnesota and University of Mainz, Germany. His work bridges academia and practical applications by emphasizing sustainable drug development from natural sources, making his research relevant both scientifically and industrially. In addition to his prolific publication record and extensive teaching responsibilities, Dr. Badria has played significant roles in academic governance and research ethics in Egypt. He is a member of multiple scientific organizations and has mentored numerous students and researchers. His commitment to scientific excellence, public health, and academic leadership makes him a worthy contender for the Best Researcher Award.

Professional Profile

Education

Dr. Badria’s educational background reflects his deep expertise in pharmacognosy, cell biology, and natural product chemistry. He holds a Ph.D. in Microbial Transformations and Natural Products Chemistry from the University of Mississippi, USA, where he conducted groundbreaking research on microbial metabolism and structural elucidation of bioactive compounds. Prior to this, he earned a Master of Science in Pharmaceutical Cell Biology and Natural Toxins from the University of Minnesota, USA. His early graduate education also includes an M.Sc. in Pharmacognosy and Natural Products Chemistry from Mansoura University, Egypt, where he began his career as a dedicated researcher. Dr. Badria earned his undergraduate degree, a B.Sc. in Pharmaceutical Sciences, from the same institution. His rigorous academic training in both Egypt and the United States provided him with a comprehensive foundation in natural sciences, advanced analytical techniques, pharmacology, and biotechnology. This diverse and multidisciplinary academic formation has empowered him to investigate complex biomedical problems, develop novel therapeutic strategies, and mentor future generations of scientists in both theoretical and applied pharmaceutical sciences. His global educational experience has also facilitated international collaboration and innovation throughout his career.

Professional Experience

Dr. Farid A. Badria has amassed extensive academic and professional experience, serving in various esteemed roles that have shaped pharmaceutical education and research in Egypt and abroad. At Mansoura University, he has held positions ranging from Assistant Professor (1990) to Full Professor (since 2000), and has served as Head of the Pharmacognosy Department, Head of Applied Drug Research, and Director of the Central Research Lab. As the founding head of the Liver Research Lab (FAB-Lab), he has led pioneering work on liver disorders, natural enzyme modulators, and phytotherapy. His international career includes Visiting Professorships in Medicinal Chemistry at the University of Minnesota (USA) and at Universität Mainz (Germany), where he contributed to research on marine-derived drugs, apoptosis, and biomarkers. He has also served as a consultant and research associate in the United States. Additionally, Dr. Badria has actively contributed to academic governance, including roles on the Supreme Pharmacy Council of Egypt, Clinical Pharmacy Program Committee, and Promotion Committee for Pharmacy Professors. His professional journey reflects a harmonious blend of research innovation, academic leadership, and societal impact. His contributions have not only enriched his institutions but also advanced pharmaceutical sciences at the global level.

Research Interest

Dr. Badria’s research interests are interdisciplinary and pioneering, integrating natural product chemistry, biotechnology, pharmacognosy, and modern therapeutic strategies. His major focus lies in identifying novel bioactive compounds from plants, marine organisms, and microbial sources for use in drug discovery and disease treatment. A core area of his research targets liver diseases, particularly fibrosis and hepatocellular carcinoma, using hepatoselective agents and early diagnostic biomarkers. He is also deeply involved in phytotherapy for skin and metabolic disorders, such as alopecia, hyperpigmentation, obesity, and diabetes, through the modulation of key enzymes like aldose reductase and glucosidase. Additionally, Dr. Badria has worked extensively on cancer diagnostics (particularly ovarian and liver cancer), retinal pathology, and viral infections using both biochemical and AI-based models. His work explores enzyme inhibition as a central therapeutic mechanism and includes studies on topoisomerase, tyrosinase, and hyaluronidase inhibitors. His holistic approach also extends to environmental research, where he has developed biomarkers to monitor marine and freshwater pollution. Overall, Dr. Badria’s research combines traditional natural medicine with cutting-edge biomedical technologies, positioning him at the forefront of translational pharmacognosy and integrative therapeutic sciences.

Research Skills

Dr. Badria possesses a comprehensive and advanced skill set in both laboratory and clinical research methodologies. His expertise in natural products chemistry is demonstrated through his extensive use of chromatographic and spectroscopic techniques (HPLC, NMR, MS, IR, UV) to isolate and characterize novel therapeutic compounds. He is highly skilled in microbial transformation, tissue culture, and biological screening assays for evaluating cytotoxicity, antiviral activity, and enzyme inhibition. His work with mammalian cell culture, tumor induction, cryogenic preservation, and plant tissue cloning reflects his deep command over pharmaceutical biotechnology. Dr. Badria also utilizes AI and computational tools in healthcare research for predictive modeling in liver cancer, obesity, and treatment decision-making. His knowledge of biomarker discovery is applied in both clinical diagnostics and environmental science, identifying indicators for diseases and pollutants in human and aquatic systems. He is adept at experimental design, pharmacological evaluation, and interdisciplinary collaboration. These skills enable him to translate theoretical insights into practical applications, particularly in liver disease therapy, cancer detection, and anti-inflammatory drug development. Dr. Badria’s methodological rigor and technical proficiency are key strengths that drive the success and innovation of his research programs.

Awards and Honors

Dr. Badria’s exceptional research achievements have been recognized with numerous prestigious awards and honors, both nationally and internationally. Most notably, he was cited by Stanford University among the top 2% most-cited scientists in Medicinal and Biomolecular Chemistry. He received the World Intellectual Property Organization (WIPO) Gold Medal in 2011 as the “Best Inventor in Egypt,” and the Third World Academy of Sciences (TWAS) Prize in 2013 for public science communication. His national accolades include multiple State Recognition Awards in Medicine from the Egyptian Academy of Science and Merit of First Class from the President of Egypt in 1998. Internationally, he was honored with the Khawarizmi International Award (Iran, 2000), the NAM S&T Fellowship, and fellowships from UNESCO and the Arab Development Fund. Dr. Badria is also a member of several elite scientific bodies including the American Association for the Advancement of Science (AAAS), New York Academy of Sciences, and the American Society of Pharmacognosy (ASP). These accolades highlight not only his research excellence but also his contributions to science policy, innovation, and knowledge dissemination across borders.

Conclusion

In conclusion, Dr. Farid A. Badria exemplifies the qualities of an outstanding researcher whose work transcends disciplinary boundaries and geographic limitations. His career is characterized by an unwavering commitment to scientific advancement, innovation in natural products research, and impactful contributions to public health, particularly in liver disease treatment and diagnostics. Through his leadership in research, education, and institutional development, he has significantly elevated the scientific standing of Mansoura University and Egypt at large. His global engagements, collaborative initiatives, and mentoring have further amplified the reach and relevance of his work. Dr. Badria’s legacy is built not only on his prolific academic output and technical expertise but also on his dedication to integrating traditional medicine with modern science for the betterment of human health. Given his comprehensive and influential body of work, he is undoubtedly a highly suitable candidate for the Best Researcher Award, representing the highest standards of research integrity, innovation, and social responsibility in the scientific community.

Publications Top Notes

  • Synthesis and biological evaluation of certain α, β-unsaturated ketones and their corresponding fused pyridines as antiviral and cytotoxic agents
    Authors: HI El-Subbagh, SM Abu-Zaid, MA Mahran, FA Badria, AM Al-Obaid
    Journal: Journal of Medicinal Chemistry 43(15), pp. 2915–2921, 2000
    Citations: 536

  • Synthesis and antitumor evaluation of some new 1,3,4-oxadiazole-based heterocycles
    Authors: S Bondock, S Adel, HA Etman, FA Badria
    Journal: European Journal of Medicinal Chemistry 48, pp. 192–199, 2012
    Citations: 266

  • Melatonin, serotonin, and tryptamine in some Egyptian food and medicinal plants
    Author: FA Badria
    Journal: Journal of Medicinal Food 5(3), pp. 153–157, 2002
    Citations: 266

  • Antioxidant and immunomodulatory constituents of henna leaves
    Authors: BR Mikhaeil, FA Badria, GT Maatooq, MMA Amer
    Journal: Zeitschrift für Naturforschung C 59(7–8), pp. 468–476, 2004
    Citations: 265

  • Design and synthesis of azolopyrimidoquinolines, pyrimidoquinazolines as antioxidant, anti-inflammatory and analgesic activities
    Authors: ABA El-Gazzar, MM Youssef, AMS Youssef, AA Abu-Hashem, FA Badria
    Journal: European Journal of Medicinal Chemistry 44(2), pp. 609–624, 2009
    Citations: 236

  • Synthesis, antimicrobial, antioxidant, anti-hemolytic and cytotoxic evaluation of new imidazole-based heterocycles
    Authors: BF Abdel-Wahab, GEA Awad, FA Badria
    Journal: European Journal of Medicinal Chemistry 46(5), pp. 1505–1511, 2011
    Citations: 212

  • Synthesis of some new pyrimido[2′,1′:2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents
    Authors: AA Abu-Hashem, MA Gouda, FA Badria
    Journal: European Journal of Medicinal Chemistry 45(5), pp. 1976–1981, 2010
    Citations: 212

  • Natural products for dental caries prevention
    Authors: FA Badria, OA Zidan
    Journal: Journal of Medicinal Food 7(3), pp. 381–384, 2004
    Citations: 189

  • Chemistry and immunomodulatory activity of frankincense oil
    Authors: BR Mikhaeil, GT Maatooq, FA Badria, MMA Amer
    Journal: Zeitschrift für Naturforschung C 58(3–4), pp. 230–238, 2003
    Citations: 179

  • Immunomodulatory triterpenoids from the oleogum resin of Boswellia carterii Birdwood
    Authors: FA Badria, BR Mikhaeil, GT Maatooq, MMA Amer
    Journal: Zeitschrift für Naturforschung C 58(7–8), pp. 505–516, 2003
    Citations: 165

Sakarie Mustafe Hidig | Medicine and Dentistry | Excellence in Research Award

Published on by Shen Awards

Dr. Sakarie Mustafe Hidig | Medicine and Dentistry | Excellence in Research Award

Researcher from Research Center Hargeisa Group Hospital, Somalia

Dr. Sakarie Mustafe Hidig is a dedicated clinical researcher and experienced surgeon with extensive international medical training and practice. Having served in various surgical departments across China and Somalia, he has developed strong expertise in hepatobiliary, gastrointestinal, trauma, and minimally invasive surgeries. Fluent in Somali, English, Chinese, Arabic, and French, Dr. Hidig’s multilingual capabilities have supported his ability to work across cultural and institutional boundaries. He is also a published author in numerous peer-reviewed journals, covering topics such as gastrointestinal bleeding, colorectal cancer surgery, trauma-related interventions, and case reports in orthopedic and abdominal surgery. His academic background, combined with practical knowledge and research insight, enables him to contribute effectively to both clinical operations and scientific advancement. With editorial board roles and peer review certifications, he is actively involved in shaping contemporary medical literature. As a member of multiple medical associations, including the Somali Medical Association, African Medical Association, and China Medical Association, Dr. Hidig continues to impact the regional and global medical communities. His commitment to patient care, clinical research, and academic excellence highlights his suitability for prestigious recognitions such as the Best Researcher Award.

Professional Profile

Education

Dr. Sakarie Mustafe Hidig possesses a strong academic foundation in the field of medicine and surgery, with a clear focus on clinical specialization and language proficiency. He earned his Doctor of Surgery from Zhejiang University, School of Medicine, where he gained advanced knowledge in surgical techniques and clinical research methodologies. Prior to this, he obtained his Master of Surgery from Xinjiang Medical University, where he deepened his understanding of general surgery and patient care. His medical journey began with a Bachelor of Medicine, Bachelor of Surgery (MBBS) from Youjiang Medical University for Nationalities, equipping him with comprehensive skills in diagnosing and managing complex medical cases. Complementing his medical training, Dr. Hidig also holds a Diploma from Guangxi University for Nationalities, School of Languages, which reflects his commitment to cultural competence and communication, vital for working in multicultural medical settings. This well-rounded educational pathway reflects both academic excellence and an adaptive mindset, allowing him to function effectively in diverse clinical and research environments. His formal qualifications from esteemed Chinese institutions have positioned him to serve in demanding healthcare systems and contribute significantly to the fields of clinical surgery and medical science.

Professional Experience

Dr. Sakarie Mustafe Hidig has amassed a wealth of professional experience in both clinical and academic settings, working with prestigious hospitals and institutions across Asia and Africa. He has served in the Division of Hepatobiliary and Pancreatic Surgery at the Fourth Affiliated Hospital, School of Medicine, Zhejiang University, where he engaged in complex surgical procedures and clinical research. He also contributed his expertise at the Affiliated Hospital of Youjiang Medical University for Nationalities and the Emergency & Trauma Surgery Department of the First Affiliated Hospital of Xinjiang Medical University, enhancing his capabilities in emergency interventions and trauma management. Additionally, he has worked in the Gastrointestinal Surgery Department of the Affiliated Hospital of Xuzhou Medical University, as well as various roles at Hargeisa Group Hospital and Hargeisa International Hospital, where he handled general and emergency surgeries. His hands-on experience across multiple departments underscores his adaptability and comprehensive surgical proficiency. Throughout his career, Dr. Hidig has consistently demonstrated a commitment to clinical excellence, patient care, and professional development. His experience spans public and private healthcare sectors, reflecting his ability to meet high clinical standards in diverse medical systems.

Research Interests

Dr. Sakarie Mustafe Hidig’s research interests are deeply rooted in clinical surgery, trauma medicine, and gastrointestinal disorders. He has explored a wide range of topics, from emergency surgery for severe chest trauma to the application of cutting-edge procedures in minimally invasive colorectal surgeries. His research often centers on improving surgical outcomes, reducing post-operative complications, and applying innovative diagnostic tools in clinical settings. He has shown a strong interest in analyzing rare and complex medical cases, such as small bowel bleeding associated with hematologic malignancies or arterial gastrointestinal fistulas, which reflect his dedication to solving challenging clinical problems. Furthermore, he is interested in comparative pharmacological studies, such as those involving amiodarone and propafenone in arrhythmia treatment, indicating his interdisciplinary approach to research. His work in knee arthroplasty and bone tumor management shows his commitment to improving orthopedic surgical care. Overall, Dr. Hidig’s research aims to bridge clinical practice with scientific inquiry, enabling evidence-based improvements in surgical procedures and patient outcomes. His interests continue to expand as he contributes to both routine and specialized areas of medical research, with a vision for developing patient-centered, efficient, and innovative surgical interventions.

Research Skills

Dr. Hidig possesses a robust set of research skills that complement his clinical expertise. He is proficient in conducting literature reviews, designing and implementing clinical research protocols, analyzing medical data, and publishing in peer-reviewed journals. A notable strength is his capability in SPSS data analysis, which he applies in interpreting surgical outcomes and clinical trials. His experience as a peer reviewer and editorial board member has refined his understanding of research quality and scholarly communication. He also excels in case study documentation, having authored several rare case reports that have been published internationally. His skills extend to laparoscopic and minimally invasive surgical techniques, where he has not only practiced but also contributed to methodological advancements through his research. Additionally, he demonstrates competence in Microsoft Office tools, crucial for creating presentations, reports, and manuscripts. With an interdisciplinary approach, he often integrates clinical observations with evidence-based research to produce impactful findings. His multilingual ability aids in cross-border collaborations and academic exchanges. Altogether, Dr. Hidig’s research skills empower him to lead clinical studies, contribute to scholarly discourse, and innovate within the surgical field.

Awards and Honors

Dr. Sakarie Mustafe Hidig has been recognized by multiple esteemed medical and research organizations for his academic and professional contributions. He holds the distinction of being a Young Research Fellow Member of the Somali Association for Science (SAS), reflecting his early recognition as an emerging leader in clinical research. His membership ID SAS/SYRFM/088/2023 signifies his formal acknowledgment within this scholarly body. Additionally, he is a Regular Fellow Member of the International Organization for Academic and Scientific Development (IOASD), which attests to his ongoing engagement in global scientific communities. Dr. Hidig is also a respected member of the Somali Medical Association, the African Medical Association, and the China Medical Association, organizations that honor excellence in healthcare practice and research. Through these affiliations, he has participated in various conferences, professional trainings, and collaborative research initiatives. His editorial board memberships and certifications as a peer reviewer further underscore the trust placed in him by academic journals and the broader research community. These accolades and roles demonstrate his dedication to advancing the frontiers of medical science and his continued influence on international platforms of surgical and clinical research.

Conclusion

In summary, Dr. Sakarie Mustafe Hidig exemplifies the ideal candidate for recognition through the Best Researcher Award. With a solid academic foundation, diverse clinical experience, and an impressive portfolio of research contributions, he brings a multifaceted approach to modern surgical science. His career reflects a continuous commitment to improving patient outcomes, advancing surgical techniques, and promoting scholarly excellence. Fluent in five languages and skilled in both qualitative and quantitative research methods, he seamlessly integrates global perspectives into his practice and publications. Dr. Hidig’s work spans complex case reports, pharmacological studies, trauma and gastrointestinal surgery, and orthopedic procedures, demonstrating a wide scope of knowledge and versatility. His active participation in academic communities, professional societies, and editorial review boards further enhances his reputation as a leader in the field. As he continues to make meaningful contributions to healthcare and clinical research, his achievements serve as a benchmark for aspiring medical professionals. Recognizing his efforts through this award would not only honor his past accomplishments but also encourage continued innovation and collaboration in the global medical community.

Publications Top Notes

  1. Exploring the Role of m7G Modification in Cancer: Mechanisms, Regulatory Proteins, and Biomarker Potential
    Authors: Y Zhang, W Xu, C Peng, S Ren, SM Hidig, C Zhang
    Journal: Cellular Signalling, 2024, Article ID: 111288
    Citations: 10

  2. Understanding the Incidence, Screening, and Burden of Cancer in Somalia: A Literature
    Authors: SM Hidig, MM Adan
    Journal: GSJ, Vol. 12 (1), 2024
    Citations: 3

  3. An Overview of Current Pancreatic Cancer Diagnosis and Treatment in China
    Author: SM Hidig
    Journal: IOASD Journal of Medical and Pharmaceutical Sciences, Vol. 1 (1), pp. 60–67, 2024
    Citations: 2

  4. High Hepatocellular Carcinoma Rates in African Nations: Challenges and Possibilities
    Author: SM Hidig
    Journal: International Journal of Recent Research in Interdisciplinary Sciences, 2024
    Citations: 2

  5. Does Mild Flexion of the Femoral Prosthesis in Total Knee Arthroplasty Result in Better Early Postoperative Outcomes?
    Authors: H Zhou, ZR Wu, XY Chen, LS Zhang, JC Zhang, SM Hidig, S Feng, et al.
    Journal: BMC Musculoskeletal Disorders, Vol. 24 (1), Article 711, 2023
    Citations: 6

  6. Diagnostic Value of Mean Platelet Volume Combined with Thromboelastography for Coagulation State after Total Knee Arthroplasty
    Authors: JH Chen, H Zhou, Q Zhang, H Wang, SM Hidig, XY Chen, S Feng
    Journal: Clinical Hemorheology and Microcirculation, Vol. 84 (3), pp. 321–331, 2023
    Citations: 4

  7. The Challenges Facing the Healthcare System in Somalia: A Review and The Way Forward
    Authors: SM Hidig, MHA Rahman Ali, GA Egeh
    Journal: Healthcare Issues, Vol. 3 (1), pp. 6–16, 2024
    Citations: 2

  8. Assessing Healthcare Challenges in Somalia: A 2024 Perspective
    Author: SM Hidig
    Journal: ACH Medical Journal, Vol. 3 (1), pp. 346–347, 2024
    Citations: 2

  9. Traditional Education and Modern Teaching in Somaliland: A Comprehensive Review
    Authors: SM Hidig, AM Saed
    Journal: Journal of Arts Humanities and Social Sciences (GASJAHSS), 2023
    Citations: 2

  10. Promotion Policy and Employee Performance in Golls Telecommunication Company in Dhahar District, Puntland, Somalia
    Author: AM Hidig
    Institution: Kampala International University, 2014
    Citations: 2

 

 

Mehmet Arif ICER | Health Professions | Young Scientist Award

Published on by Shen Awards

Assist. Prof. Dr. Mehmet Arif ICER | Health Professions | Young Scientist Award

Assistant Professor Doctor from Amasya University, Turkey

Dr. Mehmet Arif İÇER is an Assistant Professor and Head of the Department of Nutrition and Dietetics at Amasya University, Turkey. With a robust academic and research background, he has rapidly ascended into leadership roles within academia, also serving as the Vice Dean of the Faculty of Health Sciences. His academic journey is marked by excellence in nutrition science, with a particular focus on clinical nutrition, nutritional biomarkers, and metabolic health. Dr. İÇER’s research portfolio includes over 28 peer-reviewed articles published in internationally recognized journals, and his work is widely cited, earning him a position among Stanford’s Top 2% Scientists in 2024. He is actively engaged in both teaching and research, contributing to the academic community through book chapters, conference presentations, and interdisciplinary collaborations. His contributions to science have earned him not only national recognition but also growing international attention. Dr. İÇER is known for his deep interest in biochemistry, dietetics, and evidence-based clinical nutrition. His dedication to public health, teaching, and academic excellence makes him a well-rounded and highly respected young scientist in his field. His role as an academic leader and researcher exemplifies a balanced and progressive academic career in health sciences.

Professional Profile

Education

Dr. Mehmet Arif İÇER holds a comprehensive academic background in the field of Nutrition and Dietetics. He completed his Ph.D. at Gazi University in Ankara, Turkey, between 2018 and 2022, where he focused on evaluating the effects of omega-3 supplementation on serum fetuin-A levels in coronary artery disease—an important contribution to cardiovascular nutrition science. His Master of Science degree, also from Gazi University (2016–2018), examined urinary osteopontin levels and nutritional status in patients with kidney stones. These research endeavors demonstrate his early commitment to investigating nutritional biomarkers and clinical outcomes. Dr. İÇER earned his Bachelor of Science in Nutrition and Dietetics from Erciyes University, Kayseri (2009–2014). During his undergraduate studies, he also participated in the Erasmus exchange program at Semmelweis University in Budapest, Hungary, where he gained valuable international academic exposure. His educational trajectory illustrates a strong foundation in evidence-based nutrition science, combining both theoretical knowledge and clinical application. Each academic step has reinforced his expertise in clinical biochemistry, dietetics, and metabolic health. The depth and continuity of his educational background have been instrumental in shaping his current research focus, academic leadership, and instructional responsibilities at Amasya University.

Professional Experience

Dr. Mehmet Arif İÇER has a well-rounded professional career marked by both academic and administrative roles. He began as a Research Assistant at Amasya University in 2014–2015 before moving to Gazi University, where he continued in the same capacity from 2015 to 2022. During this period, he was actively involved in academic teaching, student mentorship, and collaborative research projects that spanned nutrition therapy, dietary biomarkers, and public health. His dedication and expertise earned him a faculty position as Assistant Professor at Amasya University in 2022. He quickly rose to become the Head of the Department of Nutrition and Dietetics and subsequently the Vice Dean of the Faculty of Health Sciences in 2023. These leadership roles reflect his exceptional organizational skills, administrative competence, and ability to drive academic programs forward. Dr. İÇER’s career is characterized by a dual focus on teaching and research, with a strong emphasis on advancing the quality of nutrition education and fostering interdisciplinary collaboration. His experience working in diverse institutional environments, both as a researcher and as an academic leader, positions him as a dynamic professional with the ability to influence health sciences education and research at both national and international levels.

Research Interests

Dr. Mehmet Arif İÇER’s research interests are deeply rooted in the intersection of clinical nutrition, biochemistry, and public health. He focuses on the role of dietary components and nutritional status in chronic diseases such as coronary artery disease, kidney stones, diabetes, and metabolic syndrome. His doctoral research on the impact of omega-3 fatty acids on serum fetuin-A levels highlights his interest in identifying novel biomarkers for disease diagnosis and management. He is also deeply engaged in studies exploring the relationships between diet quality, food neophobia, orthorexia nervosa, and nutritional adequacy. Another significant area of interest includes gut-brain axis modulation via dietary lipids and the implications of antioxidant dietary indexes. Dr. İÇER has contributed to the understanding of how food and nutritional habits, influenced by sociocultural factors, affect metabolic and cardiovascular health. His interdisciplinary approach often integrates elements from genomics, nutritional epidemiology, and behavioral science, aiming to provide comprehensive insights into how diet impacts health. Through collaborations, book chapters, and conference presentations, he extends his expertise to issues such as fermented foods, food labeling, and religious influences on diet. His research is both practical and innovative, targeting real-world health issues with scientific rigor.

Research Skills

Dr. Mehmet Arif İÇER possesses a diverse and advanced set of research skills critical to the field of health and nutrition sciences. His expertise spans clinical trial design, nutritional assessment, biomarker evaluation, and biochemical laboratory analysis. With strong grounding in medical nutrition therapy and clinical biochemistry, he is well-versed in analyzing how dietary interventions affect physiological markers, such as serum fetuin-A and urinary osteopontin. He demonstrates significant ability in scientific writing and interpretation of statistical data, with nearly 30 peer-reviewed publications to his name. His skills in SPSS, research methodology, and critical review enable him to evaluate both clinical and population-level health outcomes effectively. Dr. İÇER also excels in presenting research findings through scientific posters, oral presentations, and lectures. His technical proficiency extends to Microsoft Office tools, with excellent command of Word, Excel, PowerPoint, and Outlook for academic and administrative use. Furthermore, he maintains a strong knowledge base in current health technologies and is continuously updating his research toolkit. His ability to work collaboratively across disciplines and communicate scientific knowledge effectively has contributed to his success in academia. These skills make him a valuable contributor to ongoing advancements in nutrition and health research.

Awards and Honors

Dr. Mehmet Arif İÇER has received significant recognition for his scholarly contributions, the most prominent being his inclusion in the Stanford University Top 2% Scientists List in 2024, an honor that acknowledges his impactful scientific output and citation record. With a total of 980 citations and an h-index of 11, his work demonstrates both quantity and quality in terms of scientific contributions. His publications in respected international journals such as Journal of Clinical Medicine, Food Science & Nutrition, and International Journal of Environmental Health Research further attest to his academic excellence. Dr. İÇER has also contributed several book chapters and presented at numerous national and international scientific conferences. His early involvement in scientific discourse through poster and oral presentations reflects his long-standing commitment to advancing knowledge in dietetics and health sciences. His academic accolades and growing influence underscore his role as a young leader in nutrition science. In recognition of his leadership, he has also been appointed as the Head of Department and Vice Dean at Amasya University. These distinctions not only honor his academic accomplishments but also signal his potential to make enduring contributions to the field of nutrition and public health.

Conclusion

Dr. Mehmet Arif İÇER exemplifies the qualities of an outstanding young academic and researcher in the field of nutrition and health sciences. His career trajectory, from an early-stage researcher to an academic leader, reflects dedication, scholarly rigor, and a strong commitment to improving public health through science. His research contributions span critical areas such as dietary biomarkers, nutritional status, and disease prevention, aligning with global health priorities. With a well-documented record of peer-reviewed publications, international recognition, and teaching experience, Dr. İÇER has carved out a niche as a thought leader in clinical and community nutrition. His administrative roles further demonstrate his leadership abilities and vision for academic excellence. As a recipient of global recognition, including Stanford’s Top 2% Scientists listing, he stands out as a highly promising candidate for any academic or scientific distinction. Dr. İÇER’s dynamic engagement with research, education, and academic service positions him as a role model for emerging scholars in the health sciences. His continued commitment to interdisciplinary research, international collaboration, and innovation will undoubtedly contribute significantly to advancing both science and public well-being.

Publications Top Notes

  1. Title: Involvement of miRNAs in the Cluster of Metabolic Factors of MetS: Nutrition-Genome-MetS Axis
    Journal: Journal of Clinical Medicine
    Year: 2025
    Authors: Duygu Agagündüz, Menşure Nur Çelik, Burcu Deniz Güneş, Büşra Atabilen, Buse Sarıkaya, Mehmet Arif İçer, Ferenc Budán
  2. Title: Association of physical activity status with dietary energy density and nutritional adequacy
    Journal: Food Science and Technology (Brazil)
    Year: 2022
    Authors: Yesildemir, O.; Gencer Bingol, F.; Içer, M.A.; Koksal, E.
  3. Title: Effects of fetuin-A with diverse functions and multiple mechanisms on human health
    Journal: Clinical Biochemistry
    Year: 2021
    Authors: İçer, M.A.; Yıldıran, H.
  4. Title: Effects of vitamin E on neurodegenerative diseases: An update
    Journal: Acta Neurobiologiae Experimentalis
    Year: 2021
    Authors: İçer, M.A.; Arslan, N.; Gezmen-Karadag, M.
  5. Title: Effects of nutritional status on serum fetuin-A level
    Journal: Critical Reviews in Food Science and Nutrition
    Year: 2020
    Authors: İçer, M.A.; Yıldıran, H.
  6. Title: Response to the letter to the editor: Urine osteopontin: A biomarker for diagnosis of nephrolithiasis?
    Journal: Clinical Biochemistry
    Year: 2019
    Authors: İçer, M.A.; Gezmen-Karadag, M.; Sozen, S.
  7. Title: The potential effects of dietary food and beverage intakes on the risk of kidney stone formation
    Journal: Revista de Nutrição
    Year: 2019
    Authors: İçer, M.A.; Gezmen-Karadag, M.
  8. Title: Can urine osteopontin levels, which may be correlated with nutrition intake and body composition, be used as a new biomarker in the diagnosis of nephrolithiasis?
    Journal: Clinical Biochemistry
    Year: 2018
    Authors: İçer, M.A.; Gezmen-Karadag, M.; Sozen, S.
  9. Title: The multiple functions and mechanisms of osteopontin
    Journal: Clinical Biochemistry
    Year: 2018
    Authors: İçer, M.A.; Gezmen-Karadag, M.

Gollapalle Lakshminarayanshastry Viswanatha | Pharmacology | Best Researcher Award

Published on by Shen Awards

Dr. Gollapalle Lakshminarayanshastry Viswanatha | Pharmacology | Best Researcher Award

Manipal College of Pharmaceutical Sciences, MAHE, Manipal, India

Dr. Gollapalle L. Viswanatha is a distinguished pharmacologist and toxicologist with over 17 years of expertise in pharmaceutical R&D, regulatory toxicology, and preclinical research. Currently serving as a Manager at ClinChoice Pvt. Ltd., Bengaluru, he has held pivotal roles in organizations like IQVIA, The Himalaya Drug Company, and Connexios Life Sciences. A prolific academic and industry contributor, Dr. Viswanatha has authored over 100 peer-reviewed articles and delivered more than 20 expert talks in global forums. As a DABT-certified and European Registered Toxicologist (ERT), his work bridges cutting-edge science with regulatory excellence. He also serves as adjunct faculty at Manipal College of Pharmaceutical Sciences, mentoring postgraduate students and contributing to academic research. His pioneering efforts in herbal drug evaluation, regulatory documentation, and systematic reviews make him a leading voice in toxicology and pharmacology. With several novel animal models to his credit, he actively influences drug discovery and translational medicine.

Professional Profile

Educational 

Dr. Viswanatha holds a PhD in Pharmaceutical Sciences (2019) from JNTU Anantapur, with a dissertation focused on indigenous medicinal plants against stroke and epilepsy. He is board-certified by the American Board of Toxicology (DABT, 2023) and recognized as a European Registered Toxicologist (ERT, 2022). He completed a PG Diploma in Statistical Quality Control and earned a Six Sigma Green Belt from the Indian Statistical Institute (ISI), Bengaluru in 2017, both with Grade ‘A’. He holds an M. Pharm in Pharmacology (2008) from RGUHS, Bengaluru, graduating with 77% and was honored as the Best Outgoing Student. Additionally, he is a GATE and GPAT qualifier. His academic foundation is marked by a multidisciplinary understanding of pharmacology, quality systems, and toxicology. Throughout his academic journey, he has demonstrated a commitment to both practical research and methodological rigor, blending statistical competence with clinical relevance in drug discovery and safety sciences.

Professional Experience

Dr. Viswanatha has a robust professional background spanning regulatory toxicology, preclinical pharmacology, and data surveillance. Currently, he leads the toxicology division at ClinChoice Pvt. Ltd. (2021–present), overseeing cosmetic ingredient safety, CTD preparation, biocompatibility risk assessments, and toxicological risk evaluations. He formerly worked at IQVIA India Pvt. Ltd. (2014–2021) as a Senior Medical Data Reviewer, specializing in clinical trial surveillance and protocol compliance for myocardial infarction studies. Prior to that, he served as a Research Associate at The Himalaya Drug Company (2010–2014), standardizing herbal drug models, and as a Scientist at Connexios Life Sciences (2008–2010), handling PK, safety pharmacology, and toxicological assessments of NCEs. His interdisciplinary approach combines GLP compliance, regulatory documentation, safety evaluations, and project leadership. With broad expertise across pharmaceuticals, nutraceuticals, and cosmetics, he has contributed to product development from discovery to regulatory submission while mentoring cross-functional teams and managing end-to-end project execution.

Awards and Honors 

Dr. Viswanatha has received numerous accolades throughout his academic and professional journey. He was honored with the prestigious Joe-Mae International Young Scientist Award by the AMS Society in Hong Kong (2016) and was a nominee for the Dr. Achari Award at IPSCON 2012 for his work on a novel pharyngitis animal model. He earned the title of Best Outgoing Student during his M. Pharm (2006–2008) and successfully qualified in GATE 2007, GPAT 2010 & 2011. His innovative contributions include the development of novel animal models for non-infectious pharyngitis and hemorrhoids. He has been invited for over 10 expert talks, delivered 5 hands-on workshops, and reviewed articles for over 35 high-impact journals, reflecting his standing as a respected thought leader. These honors underscore his commitment to translational pharmacology, scientific innovation, and academic mentorship, bridging traditional medicine with modern pharmacological practices.

Research Interests 

Dr. Viswanatha’s research interests span preclinical pharmacology, regulatory toxicology, herbal medicine, and evidence-based drug evaluation. His work focuses on stroke, epilepsy, neurodegeneration, nephroprotection, pharyngitis, and gastrointestinal and cardiovascular pharmacology, often using rodent models. He has a strong inclination toward toxicological risk assessment (TRA), biocompatibility studies, and regulatory documentation for pharmaceuticals and cosmetics. His current pursuits involve systematic reviews and meta-analyses on both clinical and preclinical data, particularly emphasizing GABAergic modulation, anti-inflammatory agents, and flavonoids like naringin. He also contributes to safety pharmacology and real-world evidence generation. Beyond therapeutic investigations, he’s deeply involved in OECD-compliant toxicology, SCCS cosmetic safety dossiers, and ISO 10993-based device safety evaluations. His dual strength in bench science and regulatory frameworks makes his research both impactful and implementation-ready, aligning traditional pharmacological principles with global safety standards.

Research Skills

Dr. Viswanatha possesses advanced skills in in vivo and in vitro pharmacological/toxicological experimentation, including GLP-compliant animal models using rats, mice, rabbits, and guinea pigs. He is proficient in conducting acute, repeated dose, and genotoxicity studies, and safety pharmacology evaluations per ICH guidelines. He excels in meta-analysis and systematic reviews using RevMan, RoB-2, G-Power, and Newcastle-Ottawa scales, alongside regulatory documentation (CTD modules 2.4 & 2.6, CPSR, ADE/PDE/OEL assessments). He has expertise in SCCS guidelines, QSAR & AOT software tools, and data analysis using GraphPad Prism, SPSS, and Minitab. He’s also skilled in toxicological literature mining using PubMed, ECHA, PubChem, and other databases. A Six Sigma Green Belt and SQC professional, his approach blends quality systems with analytical rigor. His research strengths lie in project management, protocol development, real-world evidence integration, and regulatory toxicology strategy, making him an asset across life sciences domains.

Conclusion

Dr. Viswanatha exemplifies a rare blend of rigorous experimental pharmacology and robust regulatory toxicology. His multidisciplinary education and certifications, from PhD to international toxicology credentials, underpin his leadership in both academic and industry domains. With a strong track record in innovative animal model development, systematic reviews, and regulatory documentation, he drives preclinical-to-clinical translation effectively. His prolific publication record, awards, and advisory roles highlight a distinguished career that continues to influence global life sciences.

 Publication Top Notes

  • 🧠 Clinical study on cisplatin‑induced nephrotoxicity in humans – PA Arunkumar et al. (2012)

  • 🌿 Ethnopharmacology of Lepidium sativum Linn: A review – D Manohar et al. (2012)

  • 🍃 Antioxidant & anti-inflammatory activity of Mangifera indica leaf extracts – CG Mohan et al. (2013)

  • 🍊 Naringin’s neuroprotective neurobehavioral review/meta-analysis – GL Viswanatha et al. (2017)

  • 🍎 Isolation of antidiabetic principle from Punica granatum rinds – V Jain et al. (2012)

  • 🌳 POG‑glucose inhibits 11β‑HSD‑1 & ameliorates diet-induced diabetes – CG Mohan et al. (2013)

  • 🍋 Lemongrass oil for dexamethasone-induced hyperlipidemia – VRS Kumar et al. (2011)

  • 💊 Hepatoprotective activity of Hepax polyherbal formulation – VC Devaraj et al. (2011)

  • 🌿 Antioxidant & antimutagenic activities of Terminalia arjuna bark – GL Viswanatha et al. (2013)

  • 🩸 Rat model of hemorrhoids: anti‑hemorrhoidal study – M Azeemuddin et al. (2014)

  • 💧 LC‑MS/MS quantification of flavonoids in Moringa & Raphinus – VC Devaraj et al. (2011)

  • 🧠 Animal models of chemotherapy‑induced cognitive decline – J John et al. (2021)

  • 💡 Bacopa monnieri + rivastigmine memory reversal in rats – AHM Thippeswamy et al. (2016)

  • 🍊 Hesperidin’s neuroprotective & mitochondrial benefits – GL Viswanatha et al. (2012)

  • ⚡ Anti‑epileptic activity of Punica granatum leaf extracts – GL Viswanatha et al. (2016)

  • 🌲 Anxiolytic & anticonvulsant activity of Cedrus deodara – GL Viswanatha et al. (2009)

  • 🧠 POG‑glucose alleviates ischemia/reperfusion brain injury – GL Viswanatha et al. (2013)

  • 🧪 Anti‑ulcer effect of Raphinus sativus leaves – VC Devaraj et al. (2011)

  • 🌱 Gymnema sylvestre extract improves glucose uptake – PM Kumar et al. (2016)

  • 🍇 Phytochemical standardization of Punica granatum – V Jain et al. (2011)

  • 🌸 Anti‑fertility activity of Tabernaemontana divaricata flowers – MA Mukhram et al. (2012)

  • 🧊 Anti‑urolithiatic effect of Cedrus deodara extract – N Krishnadas et al. (2010)

  • 💩 Antidiarrheal activity of Thespesia populnea bark fractions – GL Viswanatha et al. (2011)

  • 🦴 Anti‑osteoporotic effect of herbal formula NR/CAL/06 – P Srikanta et al. (2011)

  • 🌿 Antidiarrheal activity of Lepidium sativum seed extract – D Manohar et al. (2011)

  • 🧠 Acteoside from Colebrookea – anti‑epileptic effects – GL Viswanatha et al. (2016)

  • 💊 Thienotriazines: synthesis & antihistaminic activity – GL Viswanatha et al. (2012)

  • 🧠 Punica granatum extract protects against I/R brain injury – GL Viswanatha et al. (2014)

  • 🌱 Colebrookea oppositifolia root for stroke – cerebroprotective effect – GL Viswanatha et al. (2019)

  • 💥 Anticonvulsant activity of POG‑glucose from Mangifera indica – GL Viswanatha et al. (2018)

  • 💊 Mechanisms of biochanin‑A: a pharmacological review – PV Anuranjana et al. (2010)

  • 🧬 Diabetic wound healing: update – R Keni et al. (2012)

  • 🛡️ Cardioprotective preclinical systematic review on naringin – GL Viswanatha et al. (2023)

  • 🌿 Ethnopharmacology of Lepidium sativum Linn. review – M Divanji et al. (2022)

  • 🧠 Erythrina variegata bark extract: anxiolytic & anticonvulsant – G Pitchaiah et al. (2023)

 

Nobuhiro Takahashi | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Nobuhiro Takahashi | Medicine and Dentistry | Best Researcher Award

Dermatologist from Tokai University School of Medicine, Japan

Dr. Nobuhiro Takahashi is a dedicated clinical professional specializing in dermatology, with a primary focus on inflammatory skin diseases. Currently serving as a Clinical Assistant in the Department of Dermatology at Tokai University Hospital, Kanagawa, Japan, Dr. Takahashi actively participates in both clinical practice and academic training. He has demonstrated a strong commitment to advancing patient care in outpatient dermatology. His work reflects a growing interest in combining clinical insights with research opportunities. With a solid foundation in medical education and practical experience, Dr. Takahashi shows promise for contributing significantly to dermatological research in the future.

Professional Profile

Education

Dr. Nobuhiro Takahashi completed his medical degree at Tokai University School of Medicine, Japan, graduating in March 2020. His academic training provided him with a comprehensive understanding of medical sciences, with a particular interest in dermatology developing during his studies. The rigorous curriculum at Tokai University laid the groundwork for his clinical reasoning, diagnostic skills, and patient management techniques. His education emphasized both theoretical knowledge and practical application, preparing him effectively for postgraduate clinical training and his current clinical role. Dr. Takahashi’s education continues to support his professional development and potential future contributions to clinical research.

Professional Experience

Dr. Takahashi began his professional journey as a Clinical Resident at Tokai University Hospital, where he completed a two-year postgraduate clinical training program from April 2020 to March 2022. This experience allowed him to build strong diagnostic and treatment skills across multiple medical disciplines. Since April 2022, he has been serving as a Clinical Assistant in the Department of Dermatology at Tokai University. In this role, he focuses on outpatient clinical dermatology and academic training, working closely with specialists to manage a variety of dermatological conditions. His current responsibilities allow him to blend clinical service with ongoing professional growth.

Research Interest

Dr. Takahashi’s primary research interests center around dermatology, particularly the study and management of inflammatory skin diseases. He is focused on improving clinical outcomes and advancing therapeutic strategies for these complex skin conditions. His exposure to diverse patient cases in an outpatient setting provides valuable clinical observations that can guide his research direction. While his current profile does not extensively detail research projects or publications, his interest in bridging clinical practice with academic research is evident. Dr. Takahashi is well-positioned to contribute to future dermatological studies that address common and challenging skin disorders.

Research Skills

Dr. Takahashi has developed a strong set of clinical and observational skills through his extensive outpatient dermatology practice. His ability to diagnose, monitor, and manage various skin conditions equips him with firsthand clinical insights essential for relevant and impactful research. Although specific laboratory or advanced research techniques are not detailed in his profile, his clinical experience supports potential development in clinical research methodologies, case study analysis, and patient-centered research. His ongoing academic training is expected to enhance his research capabilities further, enabling him to contribute to clinical trials and evidence-based dermatology studies.

Award and Honors

At this stage of his career, Dr. Takahashi has not yet received formal awards or honors in the field of dermatology or medical research. His professional achievements thus far reflect his dedication to clinical practice and academic growth. As he continues to develop his research portfolio and engage in scholarly activities, there is significant potential for him to earn recognition in the future. Participation in conferences, collaborative research, and contributions to peer-reviewed publications will likely pave the way for future awards and academic honors that acknowledge his efforts in advancing dermatological science.

Conclusion

In conclusion, Dr. Nobuhiro Takahashi is an emerging clinical dermatologist with a promising future in research. His solid educational background, hands-on clinical experience, and keen interest in inflammatory skin diseases demonstrate his dedication to the field. Although he currently has limited research output and formal recognitions, his trajectory indicates potential for future contributions to dermatological science. With continued clinical engagement, research involvement, and academic participation, Dr. Takahashi can develop into a respected researcher who significantly impacts both patient care and dermatological research. His career is well-positioned for continued growth and achievement.

Publication Top Note

  1. Title: A Case of Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma
  • Journal: JEADV Clinical Practice
  • Year: 2025

 

Jingwen Zhang | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Jingwen Zhang | Medicine and Dentistry | Best Researcher Award

Research Fellow from The University of Melbourne, Australia

Dr. Jingwen Zhang is an emerging epidemiologist specializing in respiratory health, particularly chronic cough in adults. Currently serving as a Research Fellow at the Allergy and Lung Health Unit, The University of Melbourne, she has demonstrated a strong commitment to impactful public health research. With academic training in clinical medicine, public health, and epidemiology, Dr. Zhang brings a unique multidisciplinary perspective to her work. Her research is recognized at both national and international levels, having received prestigious scholarships, competitive grants, and multiple awards for her presentations. She has published extensively and has provided significant contributions as a peer reviewer for leading journals, including The Lancet and New England Journal of Medicine. Beyond her research, Dr. Zhang is actively engaged in teaching, mentoring postgraduate students, organizing scientific meetings, and participating in collaborative initiatives that aim to advance respiratory health research. Her work has attracted considerable media attention, reflecting its relevance to the broader public. Dr. Zhang’s dedication to improving respiratory health outcomes, her leadership in the research community, and her drive for continuous professional development make her a distinguished figure in the field of epidemiology with great potential for future leadership on a global scale.

Professional Profile

Education

Dr. Jingwen Zhang’s academic journey is a blend of excellence in clinical and public health disciplines. She is currently pursuing her Doctor of Philosophy (Epidemiology) at The University of Melbourne, Australia, from 2019 to 2024. Her research focuses on the epidemiology of adult chronic cough, supported by the prestigious University of Melbourne and China Scholarship Council Joint Scholarship. This scholarship covers her tuition fees and provides a substantial living stipend, reflecting the competitiveness of her candidature. Prior to this, she earned a Master of Public Health with First Class Honours from The University of Melbourne in 2018, showcasing her early academic excellence in the public health domain. Her undergraduate degree in Clinical Medicine, obtained from Qingdao University, China, in 2016, provided her with a strong foundation in medical sciences. This diverse educational background equips her with critical clinical insights and advanced epidemiological skills, making her uniquely capable of translating clinical problems into population-based research solutions. Throughout her studies, Dr. Zhang has actively pursued advanced training and upskilling workshops in contemporary epidemiology, clinical trials, and causal inference, further enhancing her scientific competence and professional readiness to address complex public health issues.

Professional Experience

Dr. Jingwen Zhang’s professional journey is marked by progressive research and academic responsibilities. Since 2023, she has been working as a Research Fellow at the Allergy and Lung Health Unit, The University of Melbourne, contributing to cutting-edge respiratory health research. Between 2021 and 2023, she served as a Research Assistant at the same institution, where she supported numerous projects in chronic cough and lung health epidemiology. Her experience extends to academic teaching as a casual tutor at the Centre for Epidemiology and Biostatistics in 2021, where she taught core epidemiology subjects and developed teaching materials for advanced courses. Earlier in her career, in 2016, she worked as a teacher and administrative officer at Amio International Education in China, which provided her with valuable organizational and communication skills. Dr. Zhang’s career also reflects her active participation in scientific committee meetings, leadership in organizing collaborative research initiatives, and volunteer contributions at major scientific conferences. These experiences demonstrate her dedication to academic service and her capacity for multi-tasking across research, teaching, mentoring, and community engagement. Her sustained involvement in both the academic and clinical research environment showcases her readiness to contribute at a higher level within the international research community.

Research Interest

Dr. Jingwen Zhang’s primary research interest lies in the epidemiology of chronic cough and its broader implications for respiratory health. Her doctoral research focuses on understanding chronic cough phenotypes and identifying occupational and environmental risk factors associated with different cough types among middle-aged adults. She is particularly interested in how long-term exposure to air pollution and other environmental factors contribute to chronic respiratory conditions. Her work also explores the epidemiology of asthma-COPD overlap and interventions to improve lung function among adults and children. Dr. Zhang’s research interests extend to the development of evidence-based clinical and public health strategies for improving lung health outcomes. Additionally, she is committed to applying advanced epidemiological methods, including causal inference, longitudinal data analysis, and systematic reviews, to address pressing public health issues. She is passionate about translating complex research findings into actionable insights that can shape policy, clinical practice, and public awareness. Dr. Zhang is also actively involved in collaborative cohort studies such as TAHS and PRECURSOR, which provide large-scale data for respiratory health research. Through her multi-dimensional research focus, Dr. Zhang aims to bridge the gap between clinical observations and population health interventions, ultimately improving respiratory disease management and prevention strategies.

Research Skills

Dr. Jingwen Zhang possesses a diverse and highly applicable skill set that supports her work in epidemiology and respiratory health research. She is proficient in advanced epidemiological study designs, data cleaning, and statistical analysis, with strong expertise in using statistical software such as R and REDCap. Dr. Zhang has completed specialized training in causal inference, clinical trials, reproducible research, and contemporary epidemiology, equipping her with the methodological tools necessary for high-impact research. She has substantial experience in data management, including cleaning and processing large cohort datasets, spirometry data, and address tracking for environmental exposure studies. Dr. Zhang is also skilled in systematic reviews, meta-analyses, and longitudinal study methodologies. Additionally, she has developed teaching skills through her involvement in tutorials, course material development, and student assessment. Dr. Zhang’s experience extends to manuscript preparation, scientific communication, and peer reviewing for high-ranking journals. Her organizational capabilities are evident through her role in coordinating large research initiatives, managing academic social media platforms, and hosting scientific meetings. With strong analytical thinking, attention to detail, and effective communication, Dr. Zhang’s research skills enable her to contribute meaningfully to multidisciplinary teams and deliver impactful epidemiological research outcomes.

Awards and Honors

Throughout her academic and professional journey, Dr. Jingwen Zhang has received several prestigious awards and honors that recognize her contributions to respiratory epidemiology. In 2022, she won the Best Poster Award at the Thoracic Society of Australia and New Zealand Annual Scientific Meeting for her work on occupational risks associated with novel cough phenotypes. In 2023, she received the Golden Prize at the 4th International Cough Conference for her oral presentation on the associations between air pollutants and cough types in middle-aged adults, a recognition that included funding for accommodation and travel. Dr. Zhang was awarded the University of Melbourne and China Scholarship Council Joint Scholarship, a highly competitive program covering both tuition fees and a generous living stipend for her Ph.D. studies. She also secured the PHIRST Grant in 2021 and multiple travel grants in 2024, including the TSANZ Janet Elder International Travel Award. Dr. Zhang’s excellence extends beyond awards, as she has been invited to review manuscripts for leading journals like The Lancet, Thorax, New England Journal of Medicine, and European Respiratory Journal, showcasing her growing influence in the research community. These accolades reflect her scientific rigor, leadership potential, and dedication to improving public health outcomes.

Conclusion

Dr. Jingwen Zhang exemplifies the qualities of an outstanding early-career researcher with a promising future in the field of epidemiology and respiratory health. Her strong academic foundation, research productivity, and active participation in academic service position her as a rising leader in public health research. Dr. Zhang’s work addresses a critical gap in chronic cough epidemiology and contributes valuable knowledge with the potential to influence clinical guidelines and public health policies. She has successfully combined rigorous research with impactful community engagement and international scientific dissemination. Her role as a mentor and organizer further demonstrates her leadership and commitment to building collaborative research environments. With further opportunities to expand international collaborations, increase first-author publications in top-tier journals, and lead larger research grants, Dr. Zhang is well-positioned to achieve global recognition in her field. Her comprehensive skill set, exceptional dedication, and passion for improving respiratory health outcomes make her a highly deserving candidate for prestigious research awards and continued academic advancement. Dr. Zhang’s career trajectory reflects not only her scientific excellence but also her potential to drive meaningful change in public health both nationally and internationally.

Publications Top Notes

1. Associations Between Occupational Exposures and Cough Subclasses Among Middle‐Aged Australians

  • Authors: Jingwen Zhang, Jennifer L. Perret, Dinh S. Bui, Sheikh M. Alif, Michael J. Abramson, Anne B. Chang, Hans Kromhout, Garun S. Hamilton, Paul S. Thomas, Bircan Erbas, et al.

  • Year: 2025

2. Chronic Bronchitis in Children and Adults: Definitions, Pathophysiology, Prevalence, Risk Factors, and Consequences

  • Authors: Jingwen Zhang, Danielle F. Wurzel, Jennifer L. Perret, Caroline J. Lodge, E. Haydn Walters, Shyamali C. Dharmage

  • Year: 2024

3. Association of Novel Adult Cough Subclasses With Clinical Characteristics and Lung Function Across Six Decades of Life in a Prospective, Community-Based Cohort in Australia: An Analysis of the Tasmanian Longitudinal Health Study (TAHS)

  • Authors: Jingwen Zhang, Caroline J. Lodge, E. Haydn Walters, Anne B. Chang, Dinh S. Bui, Adrian J. Lowe, Garun S. Hamilton, Paul S. Thomas, Chamara V. Senaratna, Alan L. James, et al.

  • Year: 2024

4. A Review of the Role of Pollen in COVID-19 Infection

  • Authors: Nur Sabrina Idrose, Jingwen Zhang, Caroline J. Lodge, Bircan Erbas, Jo A. Douglass, Dinh S. Bui, Shyamali C. Dharmage

  • Year: 2023

5. Risk Factors for Chronic Cough in Adults: A Systematic Review and Meta‐Analysis

  • Authors: Jingwen Zhang, Jennifer L. Perret, Anne B. Chang, Nur S. Idrose, Dinh S. Bui, Adrian J. Lowe, Michael J. Abramson, E. Haydn Walters, Caroline J. Lodge, Shyamali C. Dharmage

  • Year: 2022

6. Serum Cytokine Concentrations and Asthma Persistence to Middle Age

  • Authors: Jingwen Zhang, Eugene H. Walters, Mimi L. K. Tang, Adrian J. Lowe, Caroline J. Lodge, Dinh Bui, Rangi Kandane‐Rathnayake, Bircan Erbas, Garun S. Hamilton, Bruce R. Thompson, et al.

  • Year: 2020

Young Un Choi | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Assist. Prof. Dr. Young Un Choi | Medicine and Dentistry | Best Researcher Award

Assistant Professor from WonJu Severance Christian Hospital, South Korea

Dr. Young Un Choi is a highly experienced Clinical Assistant Professor at Yonsei University Wonju College of Medicine, specializing in trauma surgery, emergency medicine, and critical care. Throughout his distinguished medical career, Dr. Choi has been committed to advancing trauma management and emergency surgical procedures through both clinical practice and academic research. He has accumulated extensive hands-on experience working in various hospitals, including service in international medical cooperation programs. His clinical expertise is complemented by his active engagement in numerous national and international trauma, surgery, and emergency care societies. Dr. Choi has published extensively in peer-reviewed journals, contributing significantly to the understanding of trauma mechanisms, surgical interventions, and critical care outcomes. His dedication to continuous learning is evident through his participation in globally recognized trauma certification courses and advanced surgical training programs. Dr. Choi’s research has had a positive impact on the development of trauma care protocols in South Korea, particularly in the establishment and improvement of regional trauma centers. His work addresses critical healthcare challenges, aiming to reduce mortality rates and improve the survival and recovery of severely injured patients. With a solid foundation in clinical excellence, academic rigor, and a vision for improving trauma systems, Dr. Choi stands out as a leading contributor in his field.

Professional Profile

Education

Dr. Young Un Choi has pursued a comprehensive medical education that forms the foundation of his clinical and research expertise. He began his medical studies at Inje University College of Medicine from March 2000 to February 2008, where he earned his medical degree. Demonstrating a strong interest in further specialization, he pursued a Master’s degree at the same institution from March 2011 to February 2017, focusing on advanced surgical practices and trauma management. His academic journey continued with a Ph.D. from Yonsei University Wonju College of Medicine, which he completed between March 2019 and February 2022. This doctoral program allowed him to delve deeply into the field of trauma surgery, focusing on the complex interrelationships between surgical techniques, patient outcomes, and trauma care systems. Throughout his academic development, Dr. Choi consistently balanced clinical responsibilities with advanced studies, equipping him with both theoretical knowledge and practical proficiency. His educational progression reflects a deliberate effort to strengthen his expertise in emergency medicine and critical care, positioning him to contribute meaningful advancements in these domains. The combination of medical, master’s, and doctoral degrees underscores his commitment to lifelong learning and clinical excellence, ultimately shaping him into a highly skilled and knowledgeable leader in trauma and critical care research.

Professional Experience

Dr. Young Un Choi has built an impressive career with extensive professional experience across multiple clinical and academic roles. He began his journey in 2008 as an intern doctor at Good Samsun Hospital, followed by residency training in surgery at Inje University Ilsan Paik Hospital from 2009 to 2013. His early focus on pediatric surgery led him to a short-term observer fellowship at Samsung Medical Center in 2013. From 2013 to 2015, he served as a clinical instructor in surgery at Inje University Ilsan Paik Hospital. His international exposure includes working as a medical doctor for the Korea International Cooperation Agency at the Korean-Laos Children’s Hospital between 2015 and 2016, contributing to global medical aid. In 2016, Dr. Choi joined Yonsei University as a Clinical Research Assistant Professor in trauma and intensive care, advancing through academic ranks to his current role as Clinical Associate Professor at Wonju Severance Christian Hospital. His career is marked by consistent growth in trauma surgery and critical care, and he has played a crucial role in clinical education and the development of trauma systems. His professional timeline showcases a dynamic balance between clinical excellence, academic service, and humanitarian medical missions.

Research Interest

Dr. Young Un Choi’s primary research interests focus on trauma surgery, emergency medicine, critical care management, and surgical outcomes in severely injured patients. His work consistently addresses challenges in managing complex trauma cases, particularly blunt abdominal and chest injuries, as well as the evaluation and optimization of diagnostic and surgical interventions. Dr. Choi is especially interested in improving the early identification of critical injuries, developing efficient trauma assessment methods, and refining surgical protocols to reduce mortality and complication rates. He has a strong focus on the utilization of radiographic techniques in trauma diagnosis, the prevention and management of surgical site infections, and strategies for enhancing survival in patients with severe polytrauma. Additionally, his research covers postoperative critical care and the role of advanced therapies such as immunoglobulin administration and antithrombin III in trauma patients. Dr. Choi also explores trauma care efficiency during mass gatherings and pandemics, as reflected in his study of trauma center responses during the COVID-19 outbreak. His body of research contributes to the global effort to improve trauma systems, optimize critical care practices, and develop evidence-based guidelines that can be applied both regionally and internationally.

Research Skills

Dr. Young Un Choi possesses a comprehensive skill set in trauma surgery, emergency procedures, critical care, and clinical research methodologies. He is proficient in advanced trauma life support (ATLS), emergency surgical techniques, preperitoneal pelvic packing, and hemodynamic stabilization strategies for severely injured patients. Dr. Choi is highly skilled in utilizing diagnostic tools such as chest radiography and computed tomography in emergency trauma settings, allowing for rapid and accurate injury assessment. His clinical expertise extends to the management of complex abdominal and thoracic injuries, as well as the application of advanced resuscitation protocols in critical care. In addition to his clinical abilities, Dr. Choi is adept at conducting retrospective and prospective clinical studies, employing data analysis, outcome measurement, and cohort study designs to derive meaningful conclusions from patient cases. His proficiency in multi-disciplinary trauma care and his ability to integrate research into clinical practice are evident throughout his published work. Furthermore, he has strong teaching and mentorship skills, regularly contributing to academic activities, surgical training, and national trauma courses. Dr. Choi’s unique combination of hands-on surgical skills, trauma management expertise, and rigorous clinical research make him a valuable contributor to both academic and hospital settings.

Awards and Honors

Dr. Young Un Choi’s distinguished career is supported by several certifications, memberships, and recognitions in the field of trauma and emergency medicine. He holds board certifications in general surgery, trauma surgery, critical care medicine, and emergency trauma surgery, reflecting his multi-specialty proficiency. Dr. Choi has completed numerous internationally recognized training programs, including Advanced Trauma Life Support (ATLS) from Sunnybrook Health Sciences Centre in Canada and the Definitive Surgical Trauma Care (DSTC) course in Sydney, Australia. He is certified in specialized courses such as Advanced Trauma Operative Management (ATOM) and Korean Advanced Life Support (KALS), among others. Dr. Choi is an active member of several professional societies, including the Korean Surgical Society, the Korean Society of Acute Care Surgery, the Korean Society of Traumatology, and the Korean Society of Critical Care Medicine. His involvement in these organizations signifies his dedication to continuous professional development and knowledge dissemination. In addition to his certifications and society memberships, Dr. Choi has served as an instructor for several national trauma training courses, playing a vital role in the education and training of upcoming trauma surgeons and emergency care providers. His honors and certifications underscore his expertise and leadership in the trauma field.

Conclusion

Dr. Young Un Choi is a dedicated and highly skilled trauma surgeon and clinical researcher whose contributions to emergency and critical care medicine are both extensive and impactful. His academic journey, clinical excellence, and substantial research output position him as a leader in trauma care in South Korea. Through his focused research on trauma mechanisms, surgical interventions, and critical care strategies, Dr. Choi has significantly advanced the understanding and management of severe trauma cases. His consistent participation in national and international trauma societies and his role in surgical education further highlight his influence within the medical community. Although his accomplishments are already remarkable, Dr. Choi has opportunities to expand his global collaborations, increase involvement in multicenter trials, and explore innovative technologies to further elevate his contributions to the field. His ability to balance clinical duties, research, and education is commendable and demonstrates his commitment to improving patient care and trauma system efficiency. Overall, Dr. Choi’s professional journey reflects a rare combination of surgical expertise, academic dedication, and passion for advancing trauma care, making him a deserving candidate for the Best Researcher Award.

Publications Top Notes

  • Differences in Characteristics of Trauma Between General Trauma and Suicidal Trauma–Trauma Mechanism, Injury Site, and Severity: A Single‐Center Study
    Ji Young Hyun, Yae Jun Son, SuHyun Kim, Keum Seok Bae, Jae Sik Chung, Il Hwan Park, Young Un Choi, Roberto Cirocchi
    2025

  • Mortality Trends in Chest-Abdominal Trauma Patients Before and After the Establishment of Trauma Centers in South Korea
    Dae Ryong Kang, Hye Sim Kim, Ji Young Jang, Ou-Hyen Kim, Kiyoung Kim, Un Young Choi, Jiwool Ko, Keum Seok Bae, Hongjin Shim
    2024

  • Occult Pneumothorax in Patients with Blunt Chest Trauma: Key Findings on Supine Chest Radiography
    Il Hwan Park, Chang Wan Kim, Young Un Choi, Tae Wook Kang, Jihye Lim, Chun Sung Byun
    2023

  • Association of Chest Anteroposterior Radiography with Computed Tomography in Patients with Blunt Chest Trauma
    Young Un Choi, Chang Whan Kim, JiHye Lim, Il Hwan Park, Chun Sung Byun, Roberto Cirocchi
    2023

  • Effect of Antithrombin III Administration on the Prognosis of Severe Trauma Patients with Disseminated Intravascular Coagulation
    Jae Sik Chung, Myoung Jun Kim, Young Un Choi, Jun Gi Kim, Keum Seok Bae
    2023

  • Adjuvant Intravenous Immunoglobulin Administration on Postoperative Critically Ill Patients with Secondary Peritonitis: A Retrospective Study
    Young Un Choi, Jun Gi Kim, Ji Young Jang, Tae Hwa Go, Kwangmin Kim, Keum Seok Bae, Hongjin Shim
    2023

  • Outcomes Improvement Despite Continuous Visits of Severely Injured Patients During the COVID-19 Outbreak: Experience at a Regional Trauma Centre in South Korea
    Young Un Choi
    2022

  • Determination of Risk Factors for Predicting Bladder-Urethra Injury in Cases of Pelvic Bone Fracture: A Retrospective Single Center Study
    Ji Wool Ko, Myoung Jun Kim, Young Un Choi, Hongjin Shim, Hoejeong Chung, Ji Young Jang, Keum Seok Bae, Kwangmin Kim
    2022

  • A Study on Trauma Mechanisms and Injury Sites in Patients with Blunt Abdominal Trauma
    YoungUn Choi, SuHyun Kim, JiWool Ko, MyoungJun Kim, Hongjin Shim, JaeHun Han, JiHye Lim, Kwangmin Kim, Roberto Cirocchi
    2022

  • Determination of Risk Factors Associated with Surgical Site Infection in Patients Undergoing Preperitoneal Pelvic Packing for Unstable Pelvic Fracture
    Kang Min Kim, Myoung Jun Kim, Jae Sik Chung, Ji Wool Ko, Young Un Choi, Hongjin Shim, Ji Young Jang, Keum Seok Bae, Kwangmin Kim
    2022